Description
BLOOD PRODUCTS
First action · last action
2013-10-28 · 2016-12-19
Transactions
8
First transaction's obligation
$101,613
Base + all options value (sum of deltas)
$523,714
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 8 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-28+$101,613= $101,613
- Mod P000012013-12-23+$33,871= $135,484
- Mod P000022014-01-21+$67,742= $203,226
- Mod P000032014-03-26+$32,098= $235,324
- Mod P000042014-03-31+$203,226= $438,550
- Mod P000052014-09-30+$0= $438,550
- Mod P000062014-10-02+$222,885= $661,435
- Mod P000072016-12-19-$137,721= $523,714
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-28 | +$101,613 | $101,613 | BLOOD PRODUCTS |
| Mod P00001· EXERCISE AN OPTION | 2013-12-23 | +$33,871 | $135,484 | BLOOD PRODUCTS |
| Mod P00002· EXERCISE AN OPTION | 2014-01-21 | +$67,742 | $203,226 | BLOOD PRODUCTS |
| Mod P00003· FUNDING ONLY ACTION | 2014-03-26 | +$32,098 | $235,324 | BLOOD PRODUCTS |
| Mod P00004· EXERCISE AN OPTION | 2014-03-31 | +$203,226 | $438,550 | BLOOD PRODUCTS |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2014-09-30 | +$0 | $438,550 | BLOOD PRODUCTS |
| Mod P00006· FUNDING ONLY ACTION | 2014-10-02 | +$222,885 | $661,435 | BLOOD PRODUCTS |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2016-12-19 | −$137,721 | $523,714 | BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GKT4L2JZJ622)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026D0056 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY | $0 | FY2026 |
| 36C26026N0391 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY | $70,000 | FY2026 |
| 36C24426N0344 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $1,682,246 | FY2026 |
| 36C24426D0025 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C24426N0788 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q999 · MEDICAL- OTHER | $56,268 | FY2026 |
| 36C26126N0359 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $123,337 | FY2026 |
Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126P1178 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
| 36C26126P1102 | ENVIGO RMS LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $74,586 | FY2026 |
| 36C26126P0961 | 10X GENOMICS, INC. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $34,600 | FY2026 |
| 36C26126P0997 | SIERRA RADIOPHARMACY LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $247,204 | FY2026 |
| 36C26126P1008 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26114P3311_3600_-NONE-_-NONE- · retrieved 2026-09-26.